Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Shanghai Shyndec Pharmaceutical Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
11472
First IPO Date
June 16, 2004
Key Executives
| Name | Title | Pay | Year Born |
| Xiangchen Wang | Chief Financial Officer | 0 | 1972 |
| Lei Gao | Accounting Supervisor | 0 | N/A |
| Yong Liu | President & Director | 0 | 1969 |
| Zhongxi Zhang | Vice President & Board Secretary | 0 | 1976 |
AD
Description
Shanghai Shyndec Pharmaceutical Co., Ltd., established in 1996 and headquartered in Shanghai, China, operates as a pharmaceutical enterprise. The company focuses on the global production of various drug formulations. Its primary therapeutic areas of specialization include anti-infectives, cardiovascular and cerebrovascular treatments, oncology, metabolic disorders, and endocrine system conditions.
AD
